OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Obstetrics
FDA panel backs Accutane registry to prevent drug's use by pregnant women
March 15th, 2004
Every patient in the U.S. given the acne drug Accutane must be enrolled in a national registry as part of major new steps to prevent pregnancy among women using the birth defect-causing medicine, government advisers said on February 27, 2004. The registry system would mandate that women cannot get their monthly supply of Accutane without a negative pregnancy test, and that they be told to use two forms of contraception while taking the drug. Every health worker who prescribes Accutane and every drugstore that dispenses it must be registered, too - and the drugstores must double-check that women are properly cleared before handing over the pills, said...
Source: OBGYN & Reproduction Week (2004-03-15)
|
